Spinifex Pharmaceutcals Private Limited
About Spinifex Pharmaceutcals Private Limited
Data last updated:
Spinifex Pharmaceutcals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 22 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U51909UR2017PTC007619. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹75,000. It is led by directors Ganga Dhar Yadav and Manoj Kumar Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vivek Vihar Colony Salempur Mehdood, Haridwar, Uttarakhand, India – 249402.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spinifex Pharmaceutcals Private Limited's registered office is in Haridwar, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressVivek Vihar Colony Salempur Mehdood, Haridwar, Uttarakhand, India – 249402
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Spinifex Pharmaceutcals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spinifex Pharmaceutcals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Spinifex Pharmaceutcals Private Limited, buy the company report.
Financials of Spinifex Pharmaceutcals Private Limited
FY 2025 filings availableSpinifex Pharmaceutcals Private Limited reported revenue of ₹5,499 (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 12% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 57%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spinifex Pharmaceutcals Private Limited, buy the company report.
Board of directors of Spinifex Pharmaceutcals Private Limited
Spinifex Pharmaceutcals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganga Dhar Yadav Also directs: SJDM Developers Private Limited | Director | 22 Feb 2017 | 9 Years 8 Months | Current |
| Manoj Kumar Yadav | Director | 22 Feb 2017 | 9 Years 8 Months | Current |
Peer comparison
Spinifex Pharmaceutcals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gama Exports Pvt Ltd | ₹5,750 (FY 2022) | -99.0% | Vadodara, Gujarat, India | |||
| Cashmir Biotech Private Limited | ₹5,657 (FY 2024) | -84.0% | Srinagar, Jammu and Kashmir, India | |||
| Philanthropy Pharmaceuticals Private Limited | ₹5,652 (FY 2024) | -83.0% | Nawabganj, Uttar Pradesh, India | |||
| Intoit Solutions Private Limited | ₹5,552 (FY 2025) | -94.0% | Pune, Maharashtra, India | |||
| Aquenta Chemicals Private Limited | ₹5,500 (FY 2017) | Pune, Maharashtra, India | ||||
| Spinifex Pharmaceutcals Private Limitedthis company | ₹5,499 (FY 2025) | 12.0% | Haridwar, Uttarakhand, India | |||
| Sree Vadivambigai Industrial Chemicals Private Limited | ₹5,110 (FY 2025) | -86.0% | Sivaganga, Tamil Nadu, India | |||
| Cryogenics India Limted | ₹5,100 (FY 2024) | Uttar Pradesh, India | ||||
| Regumedica Private Limited | ₹5,090 (FY 2025) | Junagadh, Gujarat, India | ||||
| Sansui Rosaline Aroma Cosmetics Private Limited | ₹5,026 (FY 2016) | -98.0% | Thane, Maharashtra, India | |||
| R.K. Sales Private Limited | ₹5,000 (FY 2025) | Patna, Bihar, India |
To see the full peer comparison of Spinifex Pharmaceutcals Private Limited, buy the company report.
Auditor
Spinifex Pharmaceutcals Private Limited is audited by M.AGRAWAL&CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.AGRAWAL&CO. | FY 2017 | 003891C |
Shareholding
The shareholding of Spinifex Pharmaceutcals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Spinifex Pharmaceutcals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spinifex Pharmaceutcals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spinifex Pharmaceutcals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spinifex Pharmaceutcals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Spinifex Pharmaceutcals Private Limited, buy the company report.
Recent activity
Spinifex Pharmaceutcals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Sadhana Kushwaha ceased to be Director on 12 Dec 2023.
Frequently asked questions
Spinifex Pharmaceutcals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in specialty, within the trading industry. It was incorporated on 22 February 2017 (9+ years old) and is registered under CIN U51909UR2017PTC007619.
Spinifex Pharmaceutcals has 2 current directors:
- Ganga Dhar Yadav - Director
- Manoj Kumar Yadav - Director
The latest financial statements of Spinifex Pharmaceutcals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
No. Spinifex Pharmaceutcals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Spinifex Pharmaceutcals is U51909UR2017PTC007619. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spinifex Pharmaceutcals was incorporated on 22 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Spinifex Pharmaceutcals by revenue are Gama Exports Pvt Ltd, Cashmir Biotech Private Limited, Philanthropy Pharmaceuticals Private Limited, Intoit Solutions Private Limited, Aquenta Chemicals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sadhana Kushwaha ceased to be Director on 12 Dec 2023. Ganga Dhar Yadav was appointed as Director on 22 Feb 2017. Manoj Kumar Yadav was appointed as Director on 22 Feb 2017.
The registered office of Spinifex Pharmaceutcals is at Vivek Vihar Colony Salempur Mehdood, Haridwar, Uttarakhand, India – 249402.
Spinifex Pharmaceutcals operates in the trading industry, in the specialty segment.
The compliance status of Spinifex Pharmaceutcals is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
